<p>Distribution of individual comorbidities among reduced intensity regimens and myeloablative patients as assessed by the NCI.</p
<p>Distribution of disease activity and severity in patients with moderate to severe TAO.</p
<p>The distribution of decorin levels between the normal control patients and the patients with NDMM...
<p>Percentage distribution of patients with osteomyelitis based on demographics and clinical charact...
Distribution of medications used to the treatment of T2DM patients with comorbidity.</p
<p>Distribution of the Charlson Comorbidity index across hospitals. In this figure the Charlson Como...
Distribution of mild, moderate, and severe patients, based on the five approaches used in the study....
<p>Comorbidity Distribution Based on the Charlson Comorbidity Index (n = 4095).</p
<p>Distribution of coinfected and non-coinfected patients according the mean of NFI at all the momen...
<p>Distributions of the demographic characteristics and the comorbid diseases between patients with ...
<p>Percentage distribution of hospitalizations of US adults and odds ratios for VTE diagnosis by num...
<p>Distribution of coinfected and non-coinfected patients according to demographical and clinical va...
<p>Percent of patients having between 0 and 8 detected medications in the Residuals vs. Reconciled c...
The distribution of medications in NPH and premixed insulin-initiated T2DM patients.</p
<p>(A) Distribution of the CCI scores (n = 18,872), excluding patients with no comorbidity (n = 5,86...
<p>Distribution of the clinical outcomes of shoulder instability patients and controls.</p
<p>Distribution of disease activity and severity in patients with moderate to severe TAO.</p
<p>The distribution of decorin levels between the normal control patients and the patients with NDMM...
<p>Percentage distribution of patients with osteomyelitis based on demographics and clinical charact...
Distribution of medications used to the treatment of T2DM patients with comorbidity.</p
<p>Distribution of the Charlson Comorbidity index across hospitals. In this figure the Charlson Como...
Distribution of mild, moderate, and severe patients, based on the five approaches used in the study....
<p>Comorbidity Distribution Based on the Charlson Comorbidity Index (n = 4095).</p
<p>Distribution of coinfected and non-coinfected patients according the mean of NFI at all the momen...
<p>Distributions of the demographic characteristics and the comorbid diseases between patients with ...
<p>Percentage distribution of hospitalizations of US adults and odds ratios for VTE diagnosis by num...
<p>Distribution of coinfected and non-coinfected patients according to demographical and clinical va...
<p>Percent of patients having between 0 and 8 detected medications in the Residuals vs. Reconciled c...
The distribution of medications in NPH and premixed insulin-initiated T2DM patients.</p
<p>(A) Distribution of the CCI scores (n = 18,872), excluding patients with no comorbidity (n = 5,86...
<p>Distribution of the clinical outcomes of shoulder instability patients and controls.</p
<p>Distribution of disease activity and severity in patients with moderate to severe TAO.</p
<p>The distribution of decorin levels between the normal control patients and the patients with NDMM...
<p>Percentage distribution of patients with osteomyelitis based on demographics and clinical charact...
DOI
Add to ORKG